Ledger.Open graph →
SEC Form D · Amendment · filed February 3, 2017

Transplant Genomics Inc

Offering
$3.5M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Other
Location
Mansfield, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Stanley Rose · Mansfield, MAExec · DirectorDarren Lee · Mansfield, MAExecMichael Abecassis · Mansfield, MADirectorRoy First · Mansfield, MAExecPeter Lewis · Mansfield, MAExecJason Mancuso · PORTLAND, ORDirectorJames S. Newman · Cupar, United KingdomExecHarshil Mathur · Palo Alto, CAExecLarry B. Donaldson · VANCOUVER, British Columbia, CanadaExec · DirectorDudley Mcdaniel · Los Alamos, NMExecGraham Downs · VANCOUVER, British Columbia, CanadaExecRosie Moore · VANCOUVER, British Columbia, CanadaDirectorDylan Arnold-Wallinger · VANCOUVER, British Columbia, CanadaExecPaul M. Sherman · Boston, MAExecAndrew M. Weiss · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗